Myxedema Coma and Thyroid Storm: Diagnosis and Management Maybelline V

Total Page:16

File Type:pdf, Size:1020Kb

Myxedema Coma and Thyroid Storm: Diagnosis and Management Maybelline V INTERNAL MEDICINE / HOSPITAL MEDICINE BOARD REVIEW MANUAL STATEMENT OF EDITORIAL PURPOSE Myxedema Coma The Internal Medicine/Hospital Medicine Board and Thyroid Storm: Review Manual is a study guide for trainees and practicing physicians preparing for board examinations in internal medicine and hos- Diagnosis and Management pital medicine. Each manual reviews a topic essential to the current practice of internal Contributors: medicine and hospital medicine. Maybelline V. Lezama, MD Assistant Professor of Medicine, Texas A&M Health Science Center College of Medicine, Temple, TX Nnenna E. Oluigbo, MD PUBLISHING STAFF Saint Mary’s Hospital, New Haven, CT Jason R. Ouellette, MD PRESIDENT, GROUP PUBLISHER Vice Chairman, Residency Program Director, Bruce M. White Department of Medicine, Saint Mary’s Hospital; Assistant Clinical Professor, Yale University School of SENIOR EDITOR Medicine, New Haven, CT Robert Litchkofski EXECUTIVE VICE PRESIDENT Barbara T. White EXECUTIVE DIRECTOR OF OPERATIONS Jean M. Gaul Table of Contents Introduction . 2 Myxedema Coma . 2 Thyroid Storm. .6 NOTE FROM THE PUBLISHER: Summary Points. 11 This publication has been developed with- out involvement of or review by the Amer- References . 11 ican Board of Internal Medicine. www.turner-white.com Internal Medicine / Hospital Medicine Volume 14, Part 2 1 Myxedema Coma and Thyroid Storm InternAl Medicine/HospitAl Medicine BOArd RevieW MANUAL Myxedema Coma and Thyroid Storm: Diagnosis and Management Maybelline V. Lezama, MD, Nnenna E. Oluigbo, MD, and Jason R. Ouellette, MD INTRODUCTION but arousable. Vital signs include: oral temperature, 95°F; heart rate, 52 bpm; blood pressure, 110/50 Thyroid storm and myxedema coma are dis- mm Hg; respiratory rate, 15 breaths/min; and oxy- orders that fall within the spectrum of endocrine gen saturation, 92% on 4 L of oxygen. The physical emergencies. Considered true medical emergen- examination in the emergency department is unre- cies, these entities should be suspected in patients markable. Notable laboratory values include: white with extreme manifestations of hypothyroidism or blood cell count (WBC), 12,000 cells/µL; sodium, 128 hyperthyroidism. Although they have a low inci- mEq/L; potassium, 5 mEq/L; blood urea nitrogen, dence, they must be promptly recognized and ade- 8 mg/dL; and creatinine, 1.5 mg/dL. The arterial quately treated in order to reduce associated mor- blood gas reveals acute respiratory acidosis with pH bidity and mortality. Aggressive treatment should of 7.23; PaCO2 of 63.7 mm Hg; and PaO2 of 71.2 be initiated in the medical intensive care unit and mm Hg on room air. Chest radiograph and head should not be delayed until the results of thyroid computed tomography are unremarkable. Diagno- function tests are available. With prompt recogni- sis of hypercapnic respiratory failure is made, and tion, morbidity and mortality related to myxedema the patient is admitted to the medical intensive care coma and thyroid storm may be diminished. unit. The patient becomes more lethargic and her respiratory acidosis worsens, requiring mechanical ventilation. A more exhaustive examination reveals MYXEDEMA COMA generalized puffiness, periorbital edema, ptosis, and macroglossia, and her extremities are dry and cool with nonpitting edema. Myxedema coma is highly CASE PRESENTATION suspected, and the patient is started on intravenous A 65-year-old woman with no known past medical levothyroxine. Her thyroxine (T4) level is below 0.35 history is brought to the emergency department with ng/dL and her thyroid-stimulating hormone level is altered mental status. On arrival, the patient is drowsy above 200 µIU/mL. Copyright 2011, Turner White Communications, Inc., Strafford Avenue, Suite 220, Wayne, PA 19087-3391, www.turner-white.com. All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, mechanical, electronic, photocopying, recording, or otherwise, without the prior written permission of Turner White Communications. The preparation and distribution of this publication are supported by sponsorship subject to written agreements that stipu- late and ensure the editorial independence of Turner White Communications. Turner White Communications retains full control over the design and production of all published materials, including selection of topics and preparation of editorial content. The authors are solely responsible for substantive content. Statements expressed reflect the views of the authors and not necessarily the opinions or policies of Turner White Communications. Turner White Communications accepts no responsibility for statements made by authors and will not be liable for any errors of omission or inaccuracies. Information contained within this publication should not be used as a substitute for clinical judgment. 2 Hospital Physician Board Review Manual www.turner-white.com Myxedema Coma and Thyroid Storm Table 1. Common Precipitating Factors of Myxedema Coma Mortality had once been estimated to range from 3 Stroke 50% to 60%. However, a high level of clinical sus- Congestive heart failure picion with earlier recognition, as well as advances Surgery in intensive care and overall management, have de- Trauma creased mortality to approximately 20% to 25%.4 Gastrointestinal bleeding Infections Drugs ETIOLOGY Anesthetics Myxedema most commonly develops in patients Amiodarone with neglected, inadequately treated, or undiag- Lithium Sedatives nosed hypothyroidism. Multiple factors appear to Metabolic disturbances precipitate myxedema coma, including the follow- Hypoglycemia ing: gastrointestinal bleeding; infection; metabolic Hypoxemia disturbances such as acidosis, hypoxemia, and Acidosis hypercapnia; stroke; and cardiovascular compro- Hypercapnia mise (Table 1).5 Many patients who develop myxedema coma are initially hospitalized with an unrelated medical OVERVIEW condition. During hospitalization, the patient slowly Myxedema coma is an extreme manifestation of develops a change in mental status. The diagno- hypothyroidism. It presents as central nervous sys- sis may not be suspected initially, especially when tem dysfunction, defective thermoregulation, and narcotics or sedatives are being used.3 cardiopulmonary decompensation. While most Drugs such as amiodarone and lithium are believe that patients must be comatose for myx- also reported as precipitants of myxedema coma, edema coma to be considered, deterioration in the especially in patients with a history of lithium- or patient’s mental status in the appropriate clinical amiodarone-induced hypothyroidism. This is due setting is enough to consider this entity.1 in part to the effects of these drugs on thyroid hormone metabolism.6,7 Lithium increases intra- EPIDEMIOLOGY thyroidal iodine content, inhibits the coupling of Myxedema coma was first reported by Ord in iodotyrosine residues to form T4 and triiodothyro- 8 1879 in London. It is a rare disorder, with only ap- nine (T3), and inhibits their secretion. Amiodarone proximately 300 cases described in the literature. has a high iodine content, and hypothyroidism can Patients are typically elderly females and often occur due to the antithyroid effects of iodine. It have longstanding, undiagnosed hypothyroidism.2 also has an effect on thyroid hormone synthesis More than 90% of cases occur during winter and release, especially in patients with underlying months, suggesting that low temperatures are a thyroid disease.6 potential contributing factor. Age-related loss of temperature regulation, in addition to a decrease in CLINICAL PRESENTATIONS heat production secondary to hypothyroidism, may The diagnosis of myxedema coma is a clinical also contribute.1 one, and virtually every organ system can be af- www.turner-white.com Internal Medicine / Hospital Medicine Volume 14, Part 2 3 Myxedema Coma and Thyroid Storm fected. Patients often present with symptoms of Respiratory dysfunction may also lead to obstruc- hypothyroidism, including excessive fatigue, weight tive sleep apnea,17 and this may be associated with gain (despite a decrease in appetite), constipation, weight gain and obesity. and cold intolerance. Atypical presentations can occur in elderly patients, who may simply exhibit Cardiovascular decreased mobility.9 Cardiovascular manifestations include bradycar- dia and low cardiac output due to decreased car- Central Nervous System diac contractility; however, frank congestive heart Altered mental status may range from mild confu- failure is rare.3 Narrow pulse pressure and diastolic sion, apathy, and lethargy to obtundation and coma. hypertension is often seen in the early stages. Hy- While all patients with myxedema coma present with potension may be seen in the later stages, and it is some degree of altered mental status, only a few frequently exacerbated by bradycardia, low cardiac present with true coma.10 Cognitive impairment (eg, output, and decreased blood volume. Increased decreased attention, motor speed, memory, and systemic peripheral resistance occurs and is thought visual/spatial organization) and psychiatric disorders to be due to decreased T3 levels. Pericardial effu- (eg, depression, dementia) are other manifestations. sions may occur as a result of increased capillary The mechanism for this change in mental status is permeability, leading to fluid accumulation. Cardiac largely unknown; however, it has been reported that tamponade, however, is rare.16 there is decreased cerebral blood flow and cerebral glucose
Recommended publications
  • Thyroid Disease Update
    10/11/2017 Thyroid Disease Update • Donald Eagerton M.D. Disclosures I have served as a clinical investigator and/or speakers bureau member for the following: Abbott, Astra Zenica, BMS, Boehringer Ingelheim, Eli Lilly, Merck, Novartis, Novo Nordisk, Pfizer, and Sanofi Aventis Thyroid Disease Update • Hypothyroidism • Hyperthyroidism • Thyroid Nodules • Thyroid Cancer 1 10/11/2017 2 10/11/2017 Case 1 • 50 year old white female is seen for follow up. Notices cold intolerance, dry skin, and some fatigue. Cholesterol is higher than prior visits. • Family history; Mother had history of hypothyroidism. Sister has hypothyroidism. • TSH = 14 (0.30- 3.3) Free T4 = 1.0 (0.95- 1.45) • Weight 70 kg Case 1 • Next step should be • A. Check Free T3 • B. Check AntiMicrosomal Antibodies • C. Start Levothyroxine 112 mcg daily • D. Start Armour Thyroid 30 mg q day • E. Check Thyroid Ultrasound Case 1 Next step should be • A. Check Free T3 • B. Check AntiMicrosomal Antibodies • C. Start Levothyroxine 112 mcg daily • D. Start Armour Thyroid 30 mg q day • E. Check Thyroid Ultrasound 3 10/11/2017 Hypothyroidism • Incidence 0.1- 2.0 % of the population • Subclinical hypothyroidism in 4-10% of the adult population • 5-8 times higher in women An FT4 test can confirm hypothyroidism 13 • In the presence of high TSH and FT4 levels in relation to the thyroid function TSH, low FT4 (free thyroxine) usually signalsTSH primary hypothyroidism12 Overt Mild Mild Overt Euthyroidism FT4 Hypothyroidism Thyrotoxicosis* Thyrotoxicosis vs. hyperthyroidism¹ While these terms are often used interchangeably, thyrotoxicosis (toxic thyroid), describes presence of too much thyroid hormone, whether caused by thyroid overproduction (hyperthyroidism); by leakage of thyroid hormone into the bloodstream (thyroiditis); or by taking too much thyroid hormone medication.
    [Show full text]
  • The Subacute Thyroiditis, Since Its First Description by De Quervain (1904), Has Been Reported Under Many Synonyms
    Endocrinol. Japon. 1964, 11 (2), 119~138 STUDIES ON SUBACUTE THYROIDITIS SHOZO SAITO Department of Radiology, School of Medicine, Gunma University, Maebashi The subacute thyroiditis, since its first description by de Quervain (1904), has been reported under many synonyms. Terms given with reference to the histo- logic features of this disease include "pseudotuberculous thyroiditis", "granulo- matous thyroiditis", "gaint-cell thyroiditis", "de Quervain's thyroiditis", "struma granulomatosa" or "struma fibrosa, giant cell variant". The clinical findings have given rise to such names as" acute and subacute nonsuppurative thyroiditis", "acute noninfectious thyroiditis"and"subacute thyroiditis" . In recent writings, the disease is most commonly referred to as subacute thyroiditis. Later, de Quervain and Giordanengo (1936) collected reports of 54 cases of the disease, appearing in the literature since de Quervain's original description, and clearly distinguished it from other forms of thyroiditis. Several years ago, the disease had been considered relatively rare, but with recent advance in endocrinology, more attentions have been drawn by it, and more reports published on it. For the past six years, the author has treated 51 cases of subacute thyroiditis, and obtained findings of interest, which are outlined in this paper. METHODS OF EXAMINATION The disease was confirmed by Silverman's needle biopsy (Crile and Rumsey, 1950; Crile and Hazard, 1951) of the thyroid in 36 of them, and the others were diagnosed by typical clinical symptoms, characteristic results of thyroidal function test and accelerated red cell sedimentation rate and its clinical course. Thyroid function test Basal metabolic rate (BMR) was examined by Knipping's method (normal range•}15%), and serum protein-bound iodine (PBI) by modification of Barker's method (Barker and Humphrey, 1950).
    [Show full text]
  • Disease/Medical Condition
    Disease/Medical Condition HYPOTHYROIDISM Date of Publication: January 27, 2017 (also known as “underactive thyroid disease”; includes congenital hypothyroidism [also known as “neonatal hypothyroidism”] and Hashimoto’s thyroiditis [also known as “autoimmune thyroiditis”]; may manifest as “cretinism” [if onsets during fetal or early life; also known as “congenital myxedema”] or “myxedema” [if onset occurs in older children and adults]) Is the initiation of non-invasive dental hygiene procedures* contra-indicated? No. ◼ Is medical consult advised? – Yes, if previously undiagnosed hypothyroidism or enlarged (or shrunken) thyroid gland is suspected1, in which case the patient/client should see his/her primary care physician. Detection early in childhood can prevent permanent intellectual impairment. – Yes, if previously diagnosed hypothyroidism is suspected to be undermedicated (with manifest signs/symptoms of hypothyroidism) or overmedicated (with manifest signs/symptoms of hyperthyroidism2), in which case the patient/client should see his/her primary care physician or endocrinologist. Major stress or illness sometimes necessitates an increase in prescribed thyroid hormone. Is the initiation of invasive dental hygiene procedures contra-indicated?** Possibly, depending on the certainty of diagnosis and level of control. ◼ Is medical consult advised? – See above. ◼ Is medical clearance required? – Yes, if undiagnosed or severe hypothyroidism is suspected. ◼ Is antibiotic prophylaxis required? – No. ◼ Is postponing treatment advised? – Yes, if undiagnosed hypothyroidism is suspected (necessitating medical assessment/management) or severe hypothyroidism is suspected (necessitating urgent medical assessment/management in order to avoid risk of myxedema coma). In general, the patient/client with mild symptoms of untreated hypothyroidism is not in danger when receiving dental hygiene therapy, and the well managed (euthyroid) patient/client requires no special regard.
    [Show full text]
  • Management of Graves Disease:€€A Review
    Clinical Review & Education Review Management of Graves Disease A Review Henry B. Burch, MD; David S. Cooper, MD Author Audio Interview at IMPORTANCE Graves disease is the most common cause of persistent hyperthyroidism in adults. jama.com Approximately 3% of women and 0.5% of men will develop Graves disease during their lifetime. Supplemental content at jama.com OBSERVATIONS We searched PubMed and the Cochrane database for English-language studies CME Quiz at published from June 2000 through October 5, 2015. Thirteen randomized clinical trials, 5 sys- jamanetworkcme.com and tematic reviews and meta-analyses, and 52 observational studies were included in this review. CME Questions page 2559 Patients with Graves disease may be treated with antithyroid drugs, radioactive iodine (RAI), or surgery (near-total thyroidectomy). The optimal approach depends on patient preference, geog- raphy, and clinical factors. A 12- to 18-month course of antithyroid drugs may lead to a remission in approximately 50% of patients but can cause potentially significant (albeit rare) adverse reac- tions, including agranulocytosis and hepatotoxicity. Adverse reactions typically occur within the first 90 days of therapy. Treating Graves disease with RAI and surgery result in gland destruction or removal, necessitating life-long levothyroxine replacement. Use of RAI has also been associ- ated with the development or worsening of thyroid eye disease in approximately 15% to 20% of patients. Surgery is favored in patients with concomitant suspicious or malignant thyroid nodules, coexisting hyperparathyroidism, and in patients with large goiters or moderate to severe thyroid Author Affiliations: Endocrinology eye disease who cannot be treated using antithyroid drugs.
    [Show full text]
  • Treating Thyroid Disease: a Natural Approach to Healing Hashimoto's
    Treating Thyroid Disease: A Natural Approach to Healing Hashimoto’s Melissa Lea-Foster Rietz, FNP-BC, BC-ADM, RYT-200 Presbyterian Medical Services Farmington, NM [email protected] Professional Disclosures I have no personal or professional affiliation with any of the resources listed in this presentation, and will receive no monetary gain or professional advancement from this lecture. Talk Objectives • Define hypothyroidism and Hashimoto’s. • Discuss various tests used to identify thyroid disease and when to treat based on patient symptoms • Discuss potential causes and identify environmental factors that contribute to disease • Describe how the gut (food sensitivities) and the adrenals (chronic stress) are connected to Hashimoto’s and how we as practitioners can work to educate patients on prevention before the need for treatment • How the use of adaptogens can enhance the treatment of Hashimoto’s and identify herbs that are showing promise in the research. • How to use food, exercise, and relaxation to improve patient outcomes. Named for Hakuro Hashimoto, a physician working in Europe in the early 1900’s. Hashimoto’s was the first autoimmune disease to be recognized in the scientific literature. It is estimated that one in five people suffer from an autoimmune disease and the numbers continue to rise. Women are more likely than men to develop an autoimmune disease, and it is believed that 75% of individuals with an autoimmune disease are female. Thyroid autoimmune disease is the most common form, and affects 7-8% of the population in the United States. Case Study Ms. R is a 30-year-old female, mother of three, who states that after the birth of her last child two years ago she has felt the following: • Loss of energy • Difficulty losing weight despite habitual eating pattern • Hair loss • Irregular menses • Joints that ache throughout the day • A general sense of sadness • Cold Intolerance • Joint and Muscle Pain • Constipation • Irregular menstruation • Slowed Heart Rate What tests would you run on Ms.
    [Show full text]
  • The Thyroid Nodule Information for Patients
    The Thyroid Nodule Information for Patients What is a thyroid nodule? operations, since fewer than 10% of the removed nodules proved to be cancer. Most removed The thyroid gland is located in the lower front nodules could have simply been observed or of the neck, below the larynx (“Adam’s apple”) treated medically. and above the collarbones. A thyroid nodule is a lump in or on the thyroid gland. Thyroid nodules It is not usually possible for a physician to are common and occur in about 4% of women determine whether a thyroid nodule is cancerous and 1% of men; they are less common in on the basis of a physical examination or younger patients and increase in frequency with blood tests. Endocrin ologists rely heavily on age. Sometimes several nodules will develop in 3 specialized tests for help in deciding which the same person. Any time a lump is discovered nodules should be treated surgically: in thyroid tissue, the possibility of malignancy (cancer) must be considered. Fortunately, the tThyroid fine needle biopsy vast majority of thyroid nodules are benign (not tThyroid scan cancerous). tThyroid ultrasonography Many patients with thyroid nodules have no symptoms whatsoever, and are found by What is a thyroid needle biopsy? chance to have a lump in the thyroid gland on a routine physical exam or an imaging study of A thyroid fine needle biopsy is a simple the neck done for unrelated reasons (CT or MRI pro ce dure that can be performed in the scan of spine or chest, carotid ultrasound, etc). physician’s office.
    [Show full text]
  • Myopathy in Acute Hypothyroidism
    Postgrad Med J: first published as 10.1136/pgmj.63.742.661 on 1 August 1987. Downloaded from Postgraduate Medical Journal (1987) 63, 661-663 Clinical Reports Myopathy in acute hypothyroidism A.W.C. Kung, J.T.C. Ma, Y.L. Yu, C.C.L. Wang, E.K.W. Woo, K.S.L. Lam, C.Y. Huang and R.T.T. Yeung Department ofMedicine, University ofHong Kong, Queen Mary Hospital, Pokfulam Road, Hong Kong. Summary: Hypothyroid myopathy has so far been reported in long standing cases ofhypothyroidism. We describe two adult patients with myopathy associated with acute transient hypothyroidism. Both presented with severe muscle aches and cramps, stiffness and spasms. Muscle enzymes were markedly elevated and electromyography in one patient showed myopathic features. Histological changes were absent in muscle biopsy, probably because of the short duration of metabolic disturbance. The myopathy subsided promptly when the hypothyroid state was reversed. Introduction Hypothyroid myopathy has been described in patients however no muscle weakness or symptoms of hypo- with long-standing hypothyroidism.' 3 We report two thyroidism. She had no preceding viral infection. Chinese patients with muscle involvement in acute Examination revealed that the goitre had decreased in copyright. transient hypothyroidism, who improved after rever- size and she was clinically euthyroid. Motor and sal of the hypothyroid state, sensory functions were completely normal. Investigation showed a T4 of 44nmol/l, triiodo- thyronine (T3) 1.2 nmol/I (normal 0.77-2.97 nmol/1), Case reports and TSH 5.1 AIU/ml (normal up to 7). The serum creatine kinase level was 11,940ILmol/min.l (normal Case I 5-165) and the lactic dehydrogenase was 397;Lmol/ min.l (normal 130-275), and glutamic-oxalacetic A 42 year old woman presented at another hospital transaminase was 120limol/min.l (normal 28-32).
    [Show full text]
  • Thyroid Nodules Update in Diagnosis and Management Shrikant Tamhane1* and Hossein Gharib2,3
    Tamhane and Gharib Clinical Diabetes and Endocrinology (2015) 1:11 DOI 10.1186/s40842-015-0011-7 REVIEW ARTICLE Open Access Thyroid nodules update in diagnosis and management Shrikant Tamhane1* and Hossein Gharib2,3 Abstract Thyroid nodules are very common. With widespread use of sensitive imaging in clinical practice, incidental thyroid nodules are being discovered with increasing frequency. Their clinical importance is primarily related to the need to exclude malignancy (4.0 to 6.5 percent of all thyroid nodules), assess for their functional status and any pressure symptoms caused by them. New Molecular tests are marketed for the assessment of thyroid nodules for the presence of cancer. The high prevalence of thyroid nodules requires evidence-based rational strategies for their differential diagnosis, risk stratification, treatment, and follow-up. This review addresses advances and controversies in thyroid nodule evaluation, including the new molecular tests, and their management considering the current guidelines and supporting evidence. Keywords: Thyroid, Thyroid Nodules, Molecular markers, Benign, Malignant, FNA, Management, Ultrasonography Introduction disorders, benign and malignant can cause thyroid nod- Thyroid nodule is a discrete lesion within the thyroid ules (Table 1) [1, 5]. gland that is radiologically distinct from the surrounding Fine needle aspiration (FNA) biopsy is the most accur- thyroid parenchyma. Thyroid nodules are common. ate method for evaluating thyroid nodules and helps to They are discovered as an accidental finding by a pa- identify patients who require surgical resection [6]. If a tient, or as an incidental finding during a routine phys- serum TSH is normal or elevated, and the nodule meets ical examination in 3 to 7 % [1] or by a radiologic criteria for sampling, the next step in the evaluation of a procedure: 67 % with ultrasonography (US) imaging, thyroid nodule is a FNA biopsy.
    [Show full text]
  • Hypothyroidism: Mimicker of Common Complaints Matthew C
    Emerg Med Clin N Am 23 (2005) 649–667 Hypothyroidism: Mimicker of Common Complaints Matthew C. Tews, DOa, Sid M. Shah, MD, FACEPb,*, Ved V. Gossain, MD, FACP, FACEPc aCollege of Osteopathic Medicine, Emergency Medicine Residency Program, Michigan State University–Lansing, P.O. Box 30480, Lansing, MI 48909, USA bMichigan State University, Attending Physician Emergency Medicine, Ingham Regional Medical, Center 401 W. Greenlawn Avenue, Lansing, MI 48910, USA cDivision of Endocrinology, Department of Medicine, Michigan State University, Lansing, MI 48909, USA Patients with hypothyroidism may present with vague symptoms such as fatigue, arthralgias, myalgias, muscle cramps, headaches, and ‘‘not feeling well.’’ These are also among the more common complaints encountered by the emergency physicians. The disease spectrum of hypothyroidism ranges from an asymptomatic, subclinical condition to the rare, life-threatening myxedema coma, and thus can be a challenging diagnosis to make. A progressive and chronic disease, hypothyroidism results from diminished thyroid hormone production. It slows metabolic functions in every organ system in the body. Commonly, clinical presentation of hypothyroidism can be confused with effects of aging in the elderly, musculoskeletal or a psychiatric illness such as depression in the younger patients. Spontaneously occurring hypothyroidism is relatively common, with prevalence between 1% to 2%, and is 10 times more common in women than in men [1]. The probability of developing spontaneous hypothyroidism increases with age, with women having a mean age at diagnosis of around 60 years [2]. A recent survey showed that 9.5% out of nearly 26,000 visitors to a statewide health fair in Colorado had elevated circulating thyroid stimulating hormone (TSH) levels, indicating underlying hypothyroidism [3].
    [Show full text]
  • Screening for Thyroid Dysfunction: U.S. Preventive Services Task Force Recommendation Statement Michael L
    Annals of Internal Medicine CLINICAL GUIDELINE Screening for Thyroid Dysfunction: U.S. Preventive Services Task Force Recommendation Statement Michael L. LeFevre, MD, MSPH, on behalf of the U.S. Preventive Services Task Force* Description: Update of the 2004 U.S. Preventive Services Task Recommendation: The USPSTF concludes that the current ev- Force (USPSTF) recommendation on screening for thyroid idence is insufficient to assess the balance of benefits and harms disease. of screening for thyroid dysfunction in nonpregnant, asymptom- atic adults. (I statement) Methods: The USPSTF reviewed the evidence on the benefits and harms of screening for subclinical and “overt” thyroid dysfunction without clinically obvious symptoms, as well as the Ann Intern Med. 2015;162:641-650. doi:10.7326/M15-0483 www.annals.org effects of treatment on intermediate and final health outcomes. For author affiliation, see end of text. * For a list of USPSTF members, see the Appendix (available at www.annals Population: This recommendation applies to nonpregnant, .org). asymptomatic adults. This article was published online first at www.annals.org on 24 March 2015. he U.S. Preventive Services Task Force (USPSTF) clinicians. Thyroid dysfunction represents a continuum Tmakes recommendations about the effectiveness of from asymptomatic biochemical changes to clinically specific preventive care services for patients without re- symptomatic disease. In rare cases, it can produce life- lated signs or symptoms. threatening complications, such as myxedema coma or It bases its recommendations on the evidence of thyroid storm (1, 2). both the benefits and harms of the service and an as- Subclinical hypothyroidism is defined as an asymp- sessment of the balance.
    [Show full text]
  • Care Step Pathway – Thyroiditis (Inflammation of the Thyroid Gland)
    Care Step Pathway – Thyroiditis (inflammation of the thyroid gland) Assessment Look: Listen: Recognize: - Appear unwell? - Appetite/weight changes? - Other immune-related toxicity? - Changes in weight since last visit? - Hot or cold intolerance? - Prior thyroid dysfunction? o Appear heavier? Thinner? - Change in energy, mood, or behavior? - Prior history of radiation therapy? - Changes in hair texture/thickness? - Palpitations? - Signs of thyroid storm (fever, tachycardia, sweating, dehydration, cardiac - Appear hot/cold? - Increased fatigue? decompensation, delirium/psychosis, liver failure, abdominal pain, - Look fatigued? - Bowel-related changes? nausea/vomiting, diarrhea) - Sweating? Constipation/diarrhea - Hyperactive or lethargic? o - Signs of airway compression - Difficulty breathing? - Shortness of breath/edema? - Clinical presentation: Occasionally thyroiditis with transient hyperthyroidism - Swollen neck? - Skin-related changes? (low TSH and high free T4) may be followed by more longstanding - Voice change (e.g., deeper voice) o Dry/oily hypothyroidism (high TSH and low free T4) - Differential diagnosis-- Primary hypothyroidism: High TSH with low free T4; secondary (central) hypothyroidism due to hypophysitis: both TSH and free T4 are low (see HCP Assessment below for more detail about testing) Grading Toxicity HYPOTHYROIDISM Definition: A disorder characterized by decreased production of thyroid hormones from the thyroid gland Asymptomatic, subclinical Asymptomatic, subclinical Symptomatic, primary Severely symptomatic, Life-threatening,
    [Show full text]
  • Endocrine Emergencies
    Endocrine Emergencies • Neuroendocrine response to Critical illness • Thyroid storm/Myxedema Coma • Adrenal Crisis/Sepsis • Hyper/Hypocalcemia • Hypoglycemia • Hyper and Hyponatremia • Pheochromocytoma crises CASE 76 year old man presents with urosepsis and is Admitted to MICU. He has chronic renal insufficiency. During his hospital course, he is intubated and treated With dopamine. Thyroid studies are performed for Inability to wean from ventilator. What labs do you want? Assessment of Thyroid Function • Hormone Levels: Total T4, Total T3 • Binding proteins: TBG, (T3*) Resin uptake • Free Hormone Levels: TSH, F T4, F T3, Free Thyroid Index, F T4 by Eq Dialysis • Radioactive Iodine uptake (RAIU); primarily for DDx of hyperthyroidism • Thyroid antibodies; TPO, Anti-Thyroglobulin, Thyroid stimulating immunoglobulins, Th receptor antibodies Labs: T4 2.4 ug/dl (5-12) T3U 40% (25-35) FTI 1.0 (1.2-4.2) FT4 0.6 (0.8-1.8) TSH 0.2 uU/ml (.4-5.0) Non-thyroidal illness • Hypothesis: NTI vs 2° Hypothyroidism –RT3 ↑ in NTI and ↓ in Hypothyroidism • Hypothesis: NTI vs Hyperthyroidism – TT3 ↓ in NTI and in ↑ Hyperthyroidism • 75 year old woman with history of hypothyroidism is found unresponsive in her home during a cold spell in houston. No heat in the home. • Exam: T° 95, BP 100/60, P 50, RR 8 • Periorbital edema, neck scar, no rub or gallop, distant heart sounds, crackles at bases, peripheral edema • ECG: Decreased voltage, runs of Torsade de pointes • Labs? Imaging? • CXR: cardiomegaly • Glucose 50 • Na+ 120, K+ 4, Cl 80, HCO3¯ 30 • BUN 30 Creat 1.4 • ABG: pH 7.25, PCO2 75, PO2 80 • CK 600 • Thyroid studies pending • Management: Manifestations of Myxedema Coma • Precipitated by infection, iatrogenic (surgery, sedation, diuretics) • Low thyroid studies • Hypothermia • Altered mental status • Hyponatremia • ↑pCO2 • ↑CK • ↑Catecholamines with ↑vascular resistance • Cardiac: low voltage, Pericardial effusion, impaired relaxation with ↓C.O.
    [Show full text]